Tel Aviv, Israel

Oren Kedem

This inventor holds 13 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Biocatch Ltd.. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oren Kedem. Retrieved from https://idiyas.com/inventor/oren-kedem-zw02uc65

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 100.0


Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 560(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Mind of Oren Kedem

Introduction:

Oren Kedem, a visionary inventor hailing from Tel Aviv, Israel, is renowned for his groundbreaking contributions to the world of technology and innovation.

Latest Patents:

Oren Kedem's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights:

With a career spanning over two decades, Oren Kedem has held key positions in leading tech companies, where he spearheaded research and development projects that have revolutionized various industries.

Collaborations:

Throughout his career, Oren Kedem has collaborated with top researchers, engineers, and scientists from around the globe, fostering a culture of innovation and excellence in all his projects.

Conclusion:

In conclusion, Oren Kedem's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his position as a trailblazing inventor in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…